-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
June 01, 2018 - Currently, there are no medications
approved by the Food and Drug Administration for the prevention … antipsychotic drugs
cannot be isolated.
7
Comparison • For KQ 1, we will include non-drug … • For KQ 2, we will include non-drug
approaches to treating delirium,
including placebo, active … Non-drug interventions will be
categorized following the scheme developed by Oh and colleagues.19 … Does antipsychotic drug use increase the risk of long
term mortality?
-
effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
October 01, 2007 - Chief among them is the indication for the
drug—a patient must have the condition for which the drug … In a randomized drug trial, the allocation of subjects to
treatment and control groups at random leads … Seeger, PharmD, DrPH, Ingenix i3 Drug Safety, 950
Winter Street, Suite 3800, Waltham, MA 02451. … by a text
search for the drug name. … Drug treatment of lipid disorders. N Engl J Med. 1999;341:
498–511.
6.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
November 03, 2011 - Pharmacological classes for migraine prevention
Drug, ATC Code* Class of Drug
ANTIEPILEPTICS … (continued)
Source: www.effectivehealthcare.ahrq.gov
Published Online: November 3, 2011
A-2
Drug … (continued)
Source: www.effectivehealthcare.ahrq.gov
Published Online: November 3, 2011
A-3
Drug … drug management.mp.
2. exp patient care team/
3. exp delivery of health care, integrated/
4. … drug surveillance.mp.
10. exp drug monitoring/
11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
-
effectivehealthcare.ahrq.gov/sites/default/files/s58.pdf
October 01, 2007 - ORIGINAL ARTICLE
Studying Prescription Drug Use and Outcomes With
Medicaid Claims Data
Strengths, Limitations … Prescription drug claims histories reflect complex and often
erratic patterns of use over time. … availability to the patient,
not actual drug-taking behavior. … Filled prescriptions, repre-
senting a necessary, though not sufficient, condition for drug
ingestion … Pharmacoepidemiol Drug
Saf. 2003;12:103–111.
16. Crystal S, Sambamoorthi U, Walkup JT, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - Food and Drug Administration, Center
for Drug Evaluation and Research. … Food and Drug Administration, Center
for Drug Evaluation and Research. … Food and Drug Administration, Center
for Drug Evaluation and Research. … Food and Drug Administration, Center
for Drug Evaluation and Research. … Food and Drug Administration, Center
for Drug Evaluation and Research.
-
effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine/research
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Opioid abuse is one of the most common forms of
prescription drug abuse. … The company submitted a new drug
application to the U.S. … Food and Drug Administration (FDA) in October 2012. … Anonymous and free prescription
drug drop off program. [internet]. … Project
Lazarus: an innovative community response to
prescription drug overdose.
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
December 01, 2015 - drug-
name=orkambi.
14. Walker J. FDA panel backs Vertex cystic-fibrosis
drug Orkambi. … drug-name=orkambi
http://www.wsj.com/articles/fda-panel-backs-vertex-cystic-fibrosis-drug-orkambi-1431462559 … Policy #DRUG.00080. [internet]. … drug-
name=pirfenidone.
71. Medica. … National drug
list: drug list - three (3) tier drug plan.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_policymaker.pdf
August 01, 2016 - Food and Drug
Administration for AUD include acamprosate (Campral®,
thrice daily), disulfiram (Antabuse … Food and Drug Administration as treatment for alcohol dependence, alcohol abuse, or AUD.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
November 01, 2017 - Food and Drug Administration. 2016 Meeting
Materials, Anesthetic and Analgesic Drug Products
Advisory … Joint meeting of the anesthetic and analgesic drug products
advisory committee and the drug safety and … Joint meeting of the anesthetic and analgesic
drug products and the drug safety and risk management … Food and Drug Administration. … Joint meeting
of anesthetic and analgesic drug products advisory
committee and drug safety and risk
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_espanol.pdf
November 01, 2016 - � Acamprosato (Campral®): Este medicamento fue aprobado
por la Food and Drug Administration (FDA,
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
October 01, 2015 - the drug cost. … In November 2014, the company submitted a new
drug application to the U.S. … Early success for Kalydeco is just the
beginning for Vertex's CF drug. … Food and Drug Administration (FDA). … Vertex's two-drug cystic fibrosis
treatment shows promise. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0128_07-01-2009.pdf
January 01, 2009 - Effective Health Care
Topic Number: 0167
Document Completion Date: 1-11-10
1
Results of Topic Selection Process & Next Steps
Generic versus brand name antiepileptic drugs for the treatment of epilepsy will be addressed as part
of a larger in-process systematic review on treatment of epilepsy t…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
July 01, 2010 - We evaluated whether early use of
this drug was consistent with the FDA-approved indications for use … The dataset included patients with a diagnosis of DM, or a
claim for a drug used to treat DM, between … (San Diego, CA), was
approved by the FDA on April 28, 2005.2 Exenatide is a first-in-class drug that … If the patient had sufficient drug-on-hand for
2
Effective Health Care Program Research Report … Discussion
The early users of this new drug (in the first six months since approval) were largely
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
July 01, 2025 - in 2022, representing the primary
drug for 31, secondary drug for 31, and tertiary drug for 16 admissions … For instance, the Drug Abuse Warning Network
(DAWN), a national database tracking drug-related emergency … College Prescription Drug
Study Key Findings Report. … Drug Abuse Warning Network
(DAWN): National Estimates from Drug-Related
Emergency Department Visits … Misuse”[Mesh] OR
“Drug Misuse”[Mesh] OR “Prescription Drug Diversion”[Mesh] OR “Substance Abuse,
Oral
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
January 01, 2020 - Food and Drug
Administration (FDA) bioequivalence study data were available for a drug or a pilot was … Narcan: FDA drug overview. [internet]. Silver
Spring (MD): U.S. … Food and Drug
Administration (FDA) [accessed 2014 May 05].
[2 p]. … Food
and Drug Administration (FDA), Center for Drug
Evaluation and Research (CDER); 2014 Apr 3. … Holder urges use of drug to combat
heroin overdoses.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
April 01, 2012 - 1
Comparative Effectiveness Review
Number 55
Drug Therapy for Rheumatoid Arthritis in
Adults: An … The Key Questions (KQs) are as
follows:
KQ1: For patients with RA, do drug therapies differ in
their … Hand searches
were conducted on the Center for Drug Evaluation and
Research (CDER) database of the … Our major findings are presented in this section by type of
drug comparison for benefits and harms ( … Drug Therapy for Rheumatoid
Arthritis in Adults: An Update.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ced%20-appendix-2.xlsx
May 29, 2025 - Application of CED to an on-label use of a drug or biological is contrary to the requirements of the … controlled trials (RTCs) and to incorporate real-world evidence (RWE) Exclude on-label use of Food and Drug … drugs and biologicals be excluded from CED restrictions Application of CED to an on-label use of a drug … Requirements for post-FDA-approval real-world evidence development that is based on coverage to label for any drug
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - evaluations and one search
capturing older versus newer antiepileptic drug evaluations. … Comparative efficacy of combination
drug therapy in refractory epilepsy. … Antiepileptic drug combinations--have
newer agents altered clinical outcomes? … Pharmacotherapy:The
Journal of Human Pharmacology & Drug
Therapy. 2012 Apr;32(4):314-22. … drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - evaluations and one search
capturing older versus newer antiepileptic drug evaluations. … Comparative efficacy of combination
drug therapy in refractory epilepsy. … Antiepileptic drug combinations--have
newer agents altered clinical outcomes? … Pharmacotherapy:The
Journal of Human Pharmacology & Drug
Therapy. 2012 Apr;32(4):314-22. … drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9.